August 17, 2026 August 17, 2026Categories New TrialsNow Enrolling: The EA1242/RxFINE-Low research study is testing how to best prevent ER-positive, HER2-negative breast cancer from returningThis clinical trial studies if some patients can avoid chemotherapy and still prevent recurrence with hormone therapy and a CDK4/6 inhibitor
August 17, 2026 August 17, 2026Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Summer 2026The latest breakthroughs in cancer treatment, managing side effects, and supporting patients during cancer care
May 14, 2026 May 14, 2026Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Spring 2026The latest breakthroughs in blood and breast cancer research, the NCI-MATCH precision medicine study, challenges faced by cancer survivors, and gaps in access to clinical trials
February 11, 2026 February 11, 2026Categories EditorialsUsing AI in research to assess breast cancer recurrence riskWhere are we with the current methods and technologies—and where are research studies taking us?